Gregory Lizée

9.1k total citations
86 papers, 3.4k citations indexed

About

Gregory Lizée is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gregory Lizée has authored 86 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 54 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Gregory Lizée's work include Immunotherapy and Immune Responses (54 papers), CAR-T cell therapy research (32 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Gregory Lizée is often cited by papers focused on Immunotherapy and Immune Responses (54 papers), CAR-T cell therapy research (32 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Gregory Lizée collaborates with scholars based in United States, Australia and China. Gregory Lizée's co-authors include Patrick Hwu, Willem W. Overwijk, Laszlo Radvanyi, Yanyan Lou, Chengwen Liu, Weiyi Peng, Yan Yang, Patrick Hwu, Suzanne L. Topalian and Monica I. Gonzales and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gregory Lizée

80 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gregory Lizée 2.2k 1.8k 1.2k 313 216 86 3.4k
Evelyn Ullrich 2.6k 1.2× 1.9k 1.1× 940 0.8× 305 1.0× 154 0.7× 116 3.6k
Hung T. Khong 1.7k 0.8× 1.9k 1.1× 980 0.8× 444 1.4× 211 1.0× 71 3.0k
Robbert M. Spaapen 1.9k 0.9× 1.8k 1.0× 1.1k 0.9× 145 0.5× 317 1.5× 49 3.4k
Fernando Aranda 1.5k 0.7× 1.3k 0.7× 644 0.5× 240 0.8× 189 0.9× 76 2.5k
Monica C. Panelli 1.8k 0.8× 1.2k 0.7× 1.2k 1.0× 223 0.7× 133 0.6× 75 3.0k
Nicole M. Haynes 2.6k 1.2× 2.3k 1.3× 1.1k 0.9× 518 1.7× 230 1.1× 58 4.2k
Weiyi Peng 2.4k 1.1× 1.6k 0.9× 867 0.7× 169 0.5× 276 1.3× 50 3.5k
Sebastian Boegel 1.8k 0.8× 1.5k 0.8× 1.1k 0.9× 163 0.5× 101 0.5× 24 2.5k
Bryon D. Johnson 1.8k 0.8× 1.9k 1.0× 939 0.8× 413 1.3× 162 0.8× 140 3.9k
Sam T. Hwang 1.7k 0.8× 1.5k 0.8× 1.2k 1.0× 197 0.6× 93 0.4× 43 3.2k

Countries citing papers authored by Gregory Lizée

Since Specialization
Citations

This map shows the geographic impact of Gregory Lizée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Lizée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Lizée more than expected).

Fields of papers citing papers by Gregory Lizée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Lizée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Lizée. The network helps show where Gregory Lizée may publish in the future.

Co-authorship network of co-authors of Gregory Lizée

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Lizée. A scholar is included among the top collaborators of Gregory Lizée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Lizée. Gregory Lizée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaudhri, Apoorvi, Gregory Lizée, Patrick Hwu, & Kunal Rai. (2024). Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment. Cancer Research. 84(7). 965–976. 7 indexed citations
2.
Altan, Mehmet, Ziyi Li, Runzhe Chen, et al.. (2024). High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. Journal for ImmunoTherapy of Cancer. 12(12). e008950–e008950. 5 indexed citations
3.
Düzağaç, Fahriye, Nan Deng, Laura Reyes-Uribe, et al.. (2024). Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology. 166(5). 787–801.e11. 17 indexed citations
4.
5.
6.
7.
Bentebibel, Salah-Eddine, Daniel Johnson, Barbara Pazdrak, et al.. (2022). 782 Intratumoral sotigalimab with pembrolizumab activates antigen-presenting cells and induces local and distant anti-tumor responses in first-line metastatic melanoma: results of a phase I/II study. Regular and Young Investigator Award Abstracts. A814–A814. 2 indexed citations
8.
Li, Fenge, et al.. (2021). Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells. 10(9). 2379–2379. 31 indexed citations
9.
Diab, Adi, Noha Abdel‐Wahab, Daniel H. Johnson, et al.. (2021). 72P Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Annals of Oncology. 32. S1403–S1403. 1 indexed citations
10.
Peng, Weiyi, Leila J. Williams, Chunyu Xu, et al.. (2019). Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma. Clinical Cancer Research. 25(21). 6406–6416. 33 indexed citations
11.
Park, Jungsun, Amjad H. Talukder, Seon Ah Lim, et al.. (2017). SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. Cancer Immunology Research. 5(8). 618–629. 24 indexed citations
12.
Antunes, Dinler A., et al.. (2017). DINC 2.0: A New Protein–Peptide Docking Webserver Using an Incremental Approach. Cancer Research. 77(21). e55–e57. 93 indexed citations
13.
Bradley, Sherille D., Zeming Chen, Brenda Melendez, et al.. (2015). BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunology Research. 3(6). 602–609. 124 indexed citations
14.
Zhang, Mao, Pariya Sukhumalchandra, Lisa S. St. John, et al.. (2012). A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia. Clinical Cancer Research. 19(1). 247–257. 19 indexed citations
15.
Peng, Weiyi, Chengwen Liu, Chunyu Xu, et al.. (2012). PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines. Cancer Research. 72(20). 5209–5218. 340 indexed citations
16.
Khalili, Jahan S., Xiaoxing Yu, Ji Wang, et al.. (2012). Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11 -Dependent Manner. Clinical Cancer Research. 18(16). 4345–4355. 112 indexed citations
17.
Hong, David S., Luis M. Vence, Gerald S. Falchook, et al.. (2012). BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency. Clinical Cancer Research. 18(8). 2326–2335. 82 indexed citations
18.
Wu, Richard C., Shujuan Liu, Jessica Chacon, et al.. (2012). Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype. Clinical Cancer Research. 18(9). 2465–2477. 19 indexed citations
19.
Qin, Yong, Sühendan Ekmekçioglu, Ping Liu, et al.. (2011). Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human Melanoma. Molecular Cancer Research. 9(11). 1537–1550. 73 indexed citations
20.
Bai, Tony R., Danyi Zhou, John‐David Aubert, et al.. (1993). Expression of β 2-adrenergic Receptor mRNA in Peripheral Lung in Asthma and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 8(3). 325–333. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelyn Ullrich Breakdown of academic impact, for papers by Hung T. Khong Breakdown of academic impact, for papers by Robbert M. Spaapen Breakdown of academic impact, for papers by Fernando Aranda Breakdown of academic impact, for papers by Monica C. Panelli Breakdown of academic impact, for papers by Nicole M. Haynes Breakdown of academic impact, for papers by Weiyi Peng Breakdown of academic impact, for papers by Sebastian Boegel Breakdown of academic impact, for papers by Bryon D. Johnson Breakdown of academic impact, for papers by Sam T. Hwang
Rankless by CCL
2026